Experiment 374485
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | INTRAGASTRIC |
| Organism | Cryptolepis sanguinolenta (ASCLEPIADACEAE) |
| Citation | BIERER,DE: FORT,DM: MENDEZ,CD: LUO,J: IMBACH,PA: DUBENKO,LG: JOLAD,SD: GERBER,RE: LITVAK,J: LU,Q: ZHANG,PS: REED,MJ: WALDECK,N: BRUENING,RC: NOAMESI,BK: HECTOR,RF: CARLSON,TJ: KING,SR:. (1998). ETHNOBOTANICAL-DIRECTED DISCOVERY OF THE ANTIHYPERGLYCEMIC PROPERTIES OF CRYPTOLEPINE: ITS ISOLATION FROM CRYPTOLEPIS SANGUINOLENTA, SYNTHESIS, AND IN VITRO AND IN VIVO ACTIVITIES.. 41(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | VS.GENETICALLY ALTERED OBESE, DIABETIC ANIMALS. |
| Dose amount | 100.0 MG |
| Number | 5 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Per unit | KG |
| Dose expression | DOSE |
| Gender | MALE |